Rheumnow Podcast cover image

The Match Game (4.14.2023)

Rheumnow Podcast

00:00

The Risks of Drug Discontinuation in RA Patients

There were significantly higher rates of major adverse cardiac events, ACS acute coronary syndromes, strokes, serious infections, herpes zoster, liver disease, and suicide. The discontinuation rate was higher with Abatassip, Inflict Somab, Golimimab, and Serdylismab. But lower on Tophocilismab or Toximab and Baracitinib.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app